Par Drugs & Chemical Complete Financial Statements
PAR • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Par Drugs & Chemical (PAR).
Downloads include all available records across all periods.
For market performance, see the
PAR stock price today
.
Profitability Ratios
Net Profit Margin
12.62%
2025 data
EBITDA Margin
21.36%
2025 data
Operating Margin
19.00%
2025 data
Return on Assets
10.92%
2025 data
Return on Equity
13.13%
2025 data
Balance Sheet Ratios
Current Ratio
13.75
2025 data
Debt to Equity
1.20
2025 data
Equity Ratio
83.19%
2025 data
Asset Turnover
0.87
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-1.0%
Year-over-Year
Net Profit Growth
-23.1%
Year-over-Year
EBITDA Growth
-22.7%
Year-over-Year
Expense Growth
+3.7%
Year-over-Year
Assets Growth
+16.7%
Year-over-Year
Equity Growth
+15.1%
Year-over-Year
Liabilities Growth
+16.7%
Year-over-Year
Operating Cash Flow Growth
-20.0%
Year-over-Year
Investing Cash Flow Growth
-316.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 102 | 103 | 96 | 96 | 75 | 61 | 56 | 46 | 42 | 49 |
| Expenses | 85 | 82 | 73 | 78 | 59 | 45 | 46 | 38 | 34 | 40 |
| EBITDA | 17 | 22 | 23 | 18 | 16 | 16 | 10 | 8 | 8 | 9 |
| Operating Profit Margin % | 13.00% | 19.00% | 24.00% | 19.00% | 22.00% | 26.00% | 17.00% | 18.00% | 19.00% | 18.00% |
| Depreciation | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Profit Before Tax | 13 | 18 | 20 | 15 | 13 | 15 | 6 | 3 | 3 | 3 |
| Tax | 3 | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 2 |
| Net Profit | 10 | 13 | 15 | 11 | 9 | 12 | 5 | 3 | 2 | 2 |
| Earnings Per Share (₹) | 7.90 | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 5.60 | 5.64 | 6.50 |
Related Pages for Par Drugs & Chemical
Additional stock information and data for PAR
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Total Assets | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Assets | 55 | 60 | 49 | 44 | 41 | 24 | 14 | 14 | 14 |
| Fixed Assets | 39 | 41 | 38 | 34 | 30 | 34 | 36 | 39 | 42 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 5 | 1 | 0 | 0 | 0 |
| Investments | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 55 | 60 | 50 | 44 | 42 | 25 | 15 | 15 | 15 |
| LIABILITIES | |||||||||
| Total Liabilities | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Liabilities | 4 | 4 | 4 | 4 | 8 | 9 | 10 | 16 | 17 |
| Non-Current Liabilities | |||||||||
| SHAREHOLDERS' EQUITY | |||||||||
| Total Equity | 99 | 86 | 71 | 60 | 52 | 41 | 29 | 21 | 20 |
| Share Capital | 12 | 12 | 12 | 12 | 6 | 6 | 5 | 9 | 9 |
| Reserves & Surplus | 87 | 73 | 59 | 48 | 46 | 35 | 25 | 13 | 11 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 16 | 20 | 13 | 8 | 12 | 8 | 2 | 4 | 9 | 7 | 9 |
| Investing Activities | -25 | -6 | -7 | -3 | 0 | -2 | 0 | -1 | -2 | 0 | 0 |
| Financing Activities | 0 | 0 | 0 | -10 | 2 | 1 | -2 | -4 | -8 | -6 | -9 |
| Net Cash Flow | -9 | 14 | 6 | -5 | 14 | 7 | 0 | 0 | -1 | 1 | -1 |